Related references
Note: Only part of the references are listed.Financial Relationships Between Pharmaceutical Companies and Rheumatologists in Japan Between 2016 and 2019
Anju Murayama et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2023)
Evaluation of financial conflicts of interest and quality of evidence in Japanese gastroenterology clinical practice guidelines
Anju Murayama et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023)
Industry Payments During the COVID-19 Pandemic to Cardiologists in the United States
Anju Murayama et al.
CJC OPEN (2023)
Trend in Industry Payments to Rheumatologists in the United States During the COVID-19 Pandemic Between 2013 and 2021
Anju Murayama et al.
JOURNAL OF RHEUMATOLOGY (2023)
Industry payments to pathologists in the USA between 2013 and 2021
Anju Murayama et al.
JOURNAL OF CLINICAL PATHOLOGY (2023)
Financial conflicts of interest between pharmaceutical companies and executive board members of internal medicine subspecialty societies in Japan between 2016 and 2020
Anju Murayama et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2023)
Evaluation of Financial and Nonfinancial Conflicts of Interest and Quality of Evidence Underlying Psoriatic Arthritis Clinical Practice Guidelines: Analysis of Personal Payments From Pharmaceutical Companies and Authors' Self-Citation Rate in Japan and the United States
Hanano Mamada et al.
ARTHRITIS CARE & RESEARCH (2023)
Pharmaceutical payments to Japanese board-certified dermatologists: a 4-year retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019
Anju Murayama et al.
SCIENTIFIC REPORTS (2023)
Cross-sectional analysis of pharmaceutical payments to Japanese board-certified gastroenterologists between 2016 and 2019
Anju Murayama et al.
BMJ OPEN (2023)
Pharmaceutical industry-sponsored meals and prescriptions of biologics for asthma
Anju Murayama
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2023)
Research and Nonresearch Industry Payments to Nephrologists in the United States between 2014 and 2021
Anju Murayama et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)
Characteristics and Distribution of Scholarship Donations From Pharmaceutical Companies to Japanese Healthcare Institutions in 2017: A Cross-sectional Analysis
Anju Murayama et al.
International Journal of Health Policy and Management (2023)
Pharmaceutical Payments to Japanese Board-Certified Head and Neck Surgeons Between 2016 and 2019
Anju Murayama et al.
OTO OPEN (2023)
A 9-Year Investigation of Healthcare Industry Payments to Pulmonologists in the United States
Anju Murayama et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2023)
Evaluation of financial conflicts of interest and drug statements in the coronavirus disease 2019 clinical practice guideline in Japan
Takanao Hashimoto et al.
CLINICAL MICROBIOLOGY AND INFECTION (2022)
Letter to the editor: Are clinical practice guidelines for hepatitis C by the American Association for the Study of Liver Diseases and Infectious Diseases Society of America evidence based? Financial conflicts of interest and assessment of quality of evidence and strength of recommendations
Anju Murayama et al.
HEPATOLOGY (2022)
Industry Payment Trends to Orthopaedic Surgeons From 2014 to 2018: An Analysis of the First 5 Years of the Open Payments Database
Nathanael D. Heckmann et al.
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (2022)
Association Between Payments by Pharmaceutical Manufacturers and Prescribing Behavior in Rheumatology
Ali Duarte-Garcia et al.
MAYO CLINIC PROCEEDINGS (2022)
Sunshine on KOLs: assessment of the nature, extent and evolution of financial ties between the leaders of professional medical associations and the pharmaceutical industry in France from 2014 to 2019: a retrospective study
Marie Clinckemaillie et al.
BMJ OPEN (2022)
Evaluation of Conflicts of Interest among Participants of the Japanese Nephrology Clinical Practice Guideline
Anju Murayama et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)
Financial and Intellectual Conflicts of Interest Among Japanese Clinical Practice Guidelines Authors for Allergic Rhinitis
Anju Murayama et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2022)
Pharmaceutical payments to Japanese certified hematologists: a retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019
Eiji Kusumi et al.
BLOOD CANCER JOURNAL (2022)
Awareness and Perceptions among Members of a Japanese Cancer Patient Advocacy Group Concerning the Financial Relationships between the Pharmaceutical Industry and Physicians
Anju Murayama et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)
Industry payments to allergists and clinical immunologists in the United States during the coronavirus disease 2019 pandemic
Anju Murayama et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2022)
Evaluation of financial relationships between Japanese certified pediatric hematologist/oncologists and pharmaceutical companies: a cross-sectional analysis of personal payments from pharmaceutical companies between 2016 and 2019
Sae Kamamoto et al.
PEDIATRIC BLOOD & CANCER (2022)
Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019
Anju Murayama et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)
Undisclosed financial conflicts of interest with pharmaceutical companies among the authors of the Esophageal Cancer Practice Guidelines 2017 by the Japan Esophageal Society
Anju Murayama et al.
DISEASES OF THE ESOPHAGUS (2022)
Nature and Trends in Personal Payments Made to the Respiratory Physicians by Pharmaceutical Companies in Japan between 2016 and 2019
Anju Murayama et al.
RESPIRATION (2022)
Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing? A Systematic Review
Aaron P. Mitchell et al.
ANNALS OF INTERNAL MEDICINE (2021)
Self-reported Financial Conflict of Interest in Nephrology Clinical Practice Guidelines
Madhuri Chengappa et al.
KIDNEY INTERNATIONAL REPORTS (2021)
Association Between Industry Marketing Payments and Prescriptions for PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors in the United States
Kosuke Inoue et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2021)
Analysis of conflict of interest policies among organizations producing clinical practice guidelines
J. Henry Brems et al.
PLOS ONE (2021)
Discrepancies in self-reported financial conflicts of interest disclosures by physicians: a systematic review
Cameron Taheri et al.
BMJ OPEN (2021)
Industry Payments to Practicing US Rheumatologists, 2014-2019
Michael S. Putman et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Industry Payments to Nephrologists in the United States
Abhinandan R. Pakanati et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2021)
Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan
Kana Yamamoto et al.
INTERNATIONAL UROGYNECOLOGY JOURNAL (2021)
Industry Payments for Otolaryngology Research: A Four-Year Analysis of the Open Payments Database
Philip R. Brauer et al.
LARYNGOSCOPE (2020)
Undisclosed payments by pharmaceutical and medical device manufacturers to authors of endoscopy guidelines in the United States
Rishi Bansal et al.
GASTROINTESTINAL ENDOSCOPY (2020)
Evaluation of Financial Conflicts of Interest Among Physician-Authors of American College of Rheumatology Clinical Practice Guidelines
Cole Wayant et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Overview and transparency of non-research payments to healthcare organizations and healthcare professionals from pharmaceutical companies in Japan: Analysis of payment data in 2016
Akihiko Ozaki et al.
HEALTH POLICY (2020)
Financial ties between leaders of influential US professional medical associations and industry: cross sectional study
Ray Moynihan et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study
Katharine Elder et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2020)
Financial conflicts of interest among National Comprehensive Cancer Network clinical practice guideline panelists in 2019
Aakash P. Desai et al.
CANCER (2020)
Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan
Anju Murayama et al.
PLOS ONE (2020)
Analysis of payments to GI physicians in theUnited States: Open payments data study
Venu Gopala Reddy Gangireddy et al.
JGH OPEN (2020)
Industry Involvement in Otolaryngology: Updates from the 2017 Open Payments Database
Elliot Morse et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2019)
Industry payments to physician journal editors
Victoria S. S. Wong et al.
PLOS ONE (2019)
Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories
Ray Moynihan et al.
BMJ OPEN (2019)
Pharmaceutical Company Payments to Executive Board Members of Professional Medical Associations in Japan
Hiroaki Saito et al.
JAMA INTERNAL MEDICINE (2019)
Undisclosed financial conflicts of interest among authors of American Society of Clinical Oncology clinical practice guidelines
Ramy R. Saleh et al.
CANCER (2019)
Association of Biologic Prescribing for Inflammatory Bowel Disease With Industry Payments to Physicians
Rishad Khan et al.
JAMA INTERNAL MEDICINE (2019)
The Association between Industry Payments and Brand-Name Prescriptions in Otolaryngologists
Elliot Morse et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2019)
Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis
Akihiko Ozaki et al.
BMJ OPEN (2019)
Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015
Piotr Ozieranski et al.
JAMA NETWORK OPEN (2019)
The Role of Industry Influence in Sinus Balloon Dilation: Trends Over Time
Shekhar K. Gadkaree et al.
LARYNGOSCOPE (2018)
The Association of Industry Payments to Physicians with Prescription of Brand-Name Intranasal Corticosteroids
Elliot Morse et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2018)
Increasing Industry Involvement in Otolaryngology: Insights from 3 Years of the Open Payments Database
Elliot Morse et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2018)
Assessment of Nonresearch Industry Payments to Otolaryngologists in 2014 and 2015
Neil Pathak et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2018)
The Receipt of Industry Payments is Associated With Prescribing Promoted Alpha-blockers and Overactive Bladder Medications
Parth K. Modi et al.
UROLOGY (2018)
Industry Payments to Cardiologists An Analysis of the Open Payments Program From 2014 to 2016
Amarnath Annapureddy et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2018)
Assessment of Pharmaceutical Company and Device Manufacturer Payments to Gastroenterologists and Their Participation in Clinical Practice Guideline Panels
Salman Nusrat et al.
JAMA NETWORK OPEN (2018)
Financial Relationships between Urologists and Industry: An Analysis of Open Payments Data
Mahir Maruf et al.
UROLOGY PRACTICE (2018)
Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin
Daniel M. Hartung et al.
JAMA NETWORK OPEN (2018)
Types and Distribution of Payments From Industry to Physicians in 2015
Kathryn R. Tringale et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Cross-sectional Analysis of the Relationship between Paranasal Sinus Balloon Catheter Dilations and Industry Payments among Otolaryngologists
Rance J. T. Fujiwara et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2017)
Awareness and attitudes of the Lebanese population with regard to physician-pharmaceutical company interaction: a survey study
Ahmad Ammous et al.
BMJ OPEN (2017)
Payments by US pharmaceutical and medical device manufacturers to US medical journal editors: retrospective - observational study
Jessica J. Liu et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Industry relationships are associated with performing a greater number of sinus balloon dilation procedures
Jean Anderson Eloy et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2017)
Payments by US pharmaceutical and medical device manufacturers to US medical journal editors: retrospective - observational study
Jessica J. Liu et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Disclosure of Industry Payments to Physicians: An Epidemiologic Analysis of Early Data From the Open Payments Program
Deborah C. Marshall et al.
MAYO CLINIC PROCEEDINGS (2016)
Industry Payments to Obstetrician-Gynecologists An Analysis of 2014 Open Payments Data
Nicole M. Tierney et al.
OBSTETRICS AND GYNECOLOGY (2016)
Exploring the Industry-Dermatologist Financial Relationship Insight From the Open Payment Data
Hao Feng et al.
JAMA DERMATOLOGY (2016)
Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries
Colette DeJong et al.
JAMA INTERNAL MEDICINE (2016)
Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs
Roy H. Perlis et al.
PLOS ONE (2016)
Knowledge, Beliefs and Attitudes of Patients and the General Public towards the Interactions of Physicians with the Pharmaceutical and the Device Industry: A Systematic Review
Racha Fadlallah et al.
PLOS ONE (2016)
Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines
Holger J. Schunemann et al.
ANNALS OF INTERNAL MEDICINE (2015)
Industry Financial Relationships in Orthopaedic Surgery: Analysis of the Sunshine Act Open Payments Database and Comparison with Other Surgical Subspecialties
Gregory L. Cvetanovich et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2015)
Industry Ties in Otolaryngology: Initial Insights from the Physician Payment Sunshine Act
Vinay K. Rathi et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2015)
Key Opinion Leaders and the Corruption of Medical Knowledge: What the Sunshine Act Will and Won't Cast Light On
Sergio Sismondo
JOURNAL OF LAW MEDICINE & ETHICS (2013)
Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians' Prescribing: A Systematic Review
Geoffrey K. Spurling et al.
PLOS MEDICINE (2010)
PATIENTS' AWARENESS OF AND ATTITUDES TOWARD GIFTS FROM PHARMACEUTICAL COMPANIES TO PHYSICIANS
James Jastifer et al.
INTERNATIONAL JOURNAL OF HEALTH SERVICES (2009)
Professional Medical Associations and Their Relationships With Industry A Proposal for Controlling Conflict of Interest
David J. Rothman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Key opinion leaders - Independent experts or drug representatives in disguise?
Ray Moynihan
BRITISH MEDICAL JOURNAL (2008)
Share Paper
